# Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)

> **NCT07266792** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 36 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Brexpiprazole Film Coated Tablets
- **DRUG:** RXULTI film coated tablet

## Key facts

- **NCT ID:** NCT07266792
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-22
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-10-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07266792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07266792, "Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07266792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*